HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anette Weyergang Selected Research

tetraphenylporphine

4/2012Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
6/2008Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anette Weyergang Research Topics

Disease

23Neoplasms (Cancer)
12/2021 - 01/2006
6Rupture
12/2021 - 01/2006
4Breast Neoplasms (Breast Cancer)
11/2021 - 04/2012
3Carcinoma (Carcinomatosis)
12/2017 - 03/2007
2Fibrosarcoma
09/2013 - 11/2006
1Necrosis
02/2020
1Ovarian Neoplasms (Ovarian Cancer)
05/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2014
1Sarcoma (Soft Tissue Sarcoma)
12/2013
1Adenocarcinoma
03/2013
1Photosensitivity Disorders (Photodermatitis)
04/2012
1Glioma (Gliomas)
04/2012
1Colonic Neoplasms (Colon Cancer)
01/2009

Drug/Important Bio-Agent (IBA)

12Photosensitizing Agents (Photosensitizers)IBA
02/2020 - 01/2006
91-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2017 - 06/2008
5Pharmaceutical PreparationsIBA
10/2018 - 11/2006
3Immunotoxins (Immunotoxin)IBA
08/2015 - 03/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014 - 06/2008
3SaporinsIBA
09/2013 - 03/2006
3di(4-sulfonatophenyl)diphenylporphineIBA
04/2012 - 11/2006
2Trastuzumab (Herceptin)FDA Link
11/2021 - 05/2015
2Gelonium multiflorum GEL proteinIBA
01/2020 - 12/2013
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2017 - 04/2014
2Cetuximab (Erbitux)FDA Link
03/2013 - 03/2007
2tetraphenylporphineIBA
04/2012 - 06/2008
2Proteins (Proteins, Gene)FDA Link
09/2011 - 03/2006
1Silicon Dioxide (Silica)FDA LinkGeneric
12/2021
1Amyloidogenic ProteinsIBA
12/2021
1Biomarkers (Surrogate Marker)IBA
11/2021
1pertuzumabIBA
11/2021
1Ado-Trastuzumab EmtansineIBA
11/2021
1Paclitaxel (Taxol)FDA LinkGeneric
11/2021
1Sunitinib (Sutent)FDA Link
02/2020
1GalactosidasesIBA
12/2017
1pheophorbide aIBA
11/2017
1Monoclonal AntibodiesIBA
08/2015
1Epithelial Cell Adhesion MoleculeIBA
08/2015
1Tyrosine Kinase InhibitorsIBA
08/2015
1AndrogensIBA
08/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2013
1RTKI cpdIBA
03/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2013
1TyrphostinsIBA
03/2013
1Singlet OxygenIBA
12/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
04/2012
1RacivirIBA
04/2012
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
04/2012
1tryptoquivalineIBA
04/2012
1AluminumIBA
04/2012
1Biological ProductsIBA
11/2010
1Sirolimus (Rapamycin)FDA Link
01/2009
1TOR Serine-Threonine KinasesIBA
01/2009
1Mitogen-Activated Protein KinasesIBA
06/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2006
1ErbB Receptors (EGF Receptor)IBA
03/2006
1Epidermal Growth Factor (EGF)IBA
03/2006

Therapy/Procedure

15Therapeutics
12/2021 - 01/2006
8Photochemotherapy (Photodynamic Therapy)
11/2017 - 09/2008
1Semiconductor Lasers
12/2017
1Radiotherapy
08/2015
1Molecular Targeted Therapy
08/2015
1Drug Therapy (Chemotherapy)
08/2015
1Palliative Care (Palliative Therapy)
08/2009